Affiliated Dermatologists & Dermatologic Surgeons P.A. Data Breach

Has Your Personal Information Been Compromised As a Result of the Affiliated Dermatologists & Dermatologic Surgeons P.A. Data Breach? 

Kehoe Law Firm, P.C. is investigating potential claims on behalf individuals whose personal information was compromised, as a result of the data breach of Affiliated Dermatologists & Dermatologic Surgeons P.A. (“Affiliated Dermatologists” or the “Company”). 

On March 5, 2024, according to a “Notice of Data Incident “[Affiliated Dermatologists] detected it was the target of a cybersecurity attack whereby an unauthorized third party gained access and left a ransom note on [the Company’s] network.”

Further, “[o]n April 10, 2024, [the Company’s] investigation determined that between March 2, 2024 and March 5, 2024, the unauthorized actor obtained access to certain systems and copied data from [Affiliated Dermatologists’] network, including the personal information of [its] patients and employees.”

The Office of the Maine Attorney General reported that 373,379 individuals were affected by the data breach of Affiliated Dermatologists.

TO LEARN MORE ABOUT THE DATA BREACH INVESTIGATION REGARDING AFFILIATED DERMATOLOGISTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

B. Riley Financial Investors May Have Legal Claims – RILY

Investors of B. Riley Financial Stock Encouraged To Contact Kehoe Law Firm, P.C. 

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of B. Riley Financial, Inc. (“B. Riley Financial” or the “Company”) (NASDAQ: RILY) failed to manage B. Riley Financial in an acceptable manner, in breach of their fiduciary duties to B. Riley Financial, and whether the Company and its shareholders suffered damages as a result.

INVESTORS OF B. RILEY FINANCIAL STOCK ARE ENCOURAGED TO CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS. 

In May 2023, B. Riley Financial entered into an agreement to assist Brian Kahn (“Kahn”) in leading a management buyout of Franchise Group, Inc. (“FRG”), a deal which was completed in August 2023. 

In November 2023, Seeking Alpha reported that “. . . Kahn, the head of [FRG], was named by Bloomberg as a possible co-conspirator in a $294 million fraud case in connection with a co-founder of Prophecy Asset Management. B. Riley [Financial] invested nearly half a billion dollars this year in [FRG].”

B. Riley Financial has acknowledged that it had invested $281.1 million in the management buyout and had made a separate $201 million loan to Kahn’s investment firm secured by Kahn’s ownership interest in FRG common stock.

According to The Wall Street Journal, the stated value of the loan and the equity stake, combined, exceeds B. Riley Financial’s shareholder equity.

B. RILEY FINANCIAL INVESTORS ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE BREACH OF FIDUCIARY DUTIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Sav-RX Data Breach Impacts More Than 2.8 Million Individuals

A&A Services, d/b/a Sav-Rx, Data Breach – Kehoe Law Firm, P.C. Investigating Potential Claims on Behalf of Individuals Whose Personal Information May Have Been Compromised

According to the Office of the Maine Attorney General, the Sav-Rx data breach affected 2,812,336 individuals, including 5,935 Maine residents; occurred on October 8, 2023; and was discovered on April 30, 2024.

In a data breach notification letter contained on Sav-Rx’s website, Sav-Rx, a company that provides “medication benefit management services to health plans,” stated that “[a]s part of [its] investigation, [Sav-Rx] learned that an unauthorized third party was able to access certain non-clinical systems and obtained files that contained personal information.”

TO LEARN MORE ABOUT THE SAV-RX DATA BREACH INVESTIGATION, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

Sav-Rx Data Breach Investigation

 

Cencora Data Breach

Cencora Data Breach Reportedly Involving Personal and Sensitive Medical Information  

Kehoe Law Firm, P.C. is investigating potential claims on behalf of individuals affected by a data breach reported by Cencora, Inc. (“Cencora”)

Cencora previously reported that “[o]n February 21, 2024, Cencora . . . learned that data from its information systems had been exfiltrated, some of which may contain personal information.”

On May 24, 2024, Techcrunch.com reported that “U.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year.”

Techcrunch.com also reported that “[i]n letters to affected individuals sent out this week, Cencora said that the data from its systems includes patient names, their postal address and date of birth, as well as information about their health diagnosis and medications.”

Additionally, TechCrunch.com reported that “[a]ccording to the public data breach notifications filed by Cencora with U.S. state authorities, which TechCrunch has seen, Cencora has so far notified about half a million individuals since learning of the data breach. The number of individuals affected by the Cencora data breach is expected to be far higher. Cencora says on its website that it has served at least 18 million patients to date.”

TO LEARN MORE ABOUT THE CENCORA DATA BREACH INVESTIGATION, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm Files Shareholder Derivative Action Against Medical Properties Trust, Inc.’s Officers and Directors

Kehoe Law Firm, specializing in shareholder rights litigation, jointly filed a shareholder derivative action in the U.S. District Court for the District of Maryland against certain officers and directors of Medical Properties Trust Inc. (“Medical Properties”). The complaint seeks to remedy alleged wrongdoing from July 15, 2019, to January 5, 2024. 

Medical Properties previously acquired numerous hospitals and behavioral health facilities, including fourteen acute care hospitals and two behavioral health facilities owned by Prospect Medical Holdings, Inc. The complaint alleges that Medical Properties failed to properly disclose the underperformance of this asset portfolio, misleading investors about the true financial health of its medical provider tenants.

The truth began to surface on January 26, 2023, with the release of a report by Viceroy Research LLC, alleging that Medical Properties had engaged in billions of dollars of uncommercial transactions with its tenants and their management teams, purportedly to mask a revenue round-robin scheme, creating an illusion of positive payment histories for distressed tenants and thereby avoid impairment charges.

On February 23, 2023, Medical Properties disclosed a $283 million impairment charge related to its assets. Subsequently, on January 4, 2024, the company revealed further alleged breaches of fiduciary duties, including approximately $50 million in unpaid rent owed by its largest tenant.

As a result of these revelations, the price per share of Medical Properties’ common stock experienced significant declines, causing substantial harm to shareholders. The complaint also alleges that five of the Individual Defendants engaged in lucrative insider trading, selling over $58 million worth of common stock while the stock price was alleged to have been artificially inflated.

For more information about Kehoe Law Firm and its involvement in this matter, please contact Michael Yarnoff at [email protected] or call (215) 792-6676.